Sleep Disorders

Sleep disturbances can exacerbate TBI symptoms. Here’s how to address them.

Many individuals do not get medical support for insomnia. Here's how you can help.

Cognitive and psychiatric symptoms at 3 months post-stroke might predict daytime sleepiness and fatigue at 12 months.

Survey results shed light on the effects of insomnia and obstacles to effective treatment.

Drs Paul Doghramji and Leslie Citrome share approaches to communicate with patients and increase awareness of insomnia disorder

Experts discuss daridorexant efficacy and safety data, and dosing considerations and what to communicate with patients when using daridorexant for insomnia.

Drs Paul Doghramji and Leslie Citrome provide an overview of dual orexin receptor antagonists (DORAs), suvorexant, lemborexant, and daridorexant, in treatment of insomnia disorder.

New research explores the impact of GAT on TGNC youth.

Drs Paul Doghramji and Leslie Citrome discuss the sleep and wakefulness signals and pathways that contribute to insomnia.

Drs Paul Doghramji and Leslie Citrome review the use of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) to assess treatment efficacy.

Experts discuss treatment for patients experiencing insomnia in conjunction with other health conditions.

Drs Paul Doghramji and Leslie Citrome review prescription drugs and over-the-counter remedies for treating insomnia.

Experts highlight cognitive behavioral therapy for insomnia (CBTI) and sleep hygiene as nonpharmacological approaches to the treatment of insomnia.

Drs Paul Doghramji and Leslie Citrome discuss daytime sleepiness and other symptoms of insomnia and their impact on quality of life.

Experts review the co-occurrence of insomnia with other medical conditions and discuss risks and triggers that lead to insomnia, such as age and psychiatric conditions.

Drs Paul Doghramji and Leslie Citrome provide an overview of the diagnosis and prevalence of insomnia.

Connections between autism risk, sleep disturbances, insomnia risk genes and circadian pathways were analyzed.

From herbal medicine for psychiatrists to the psychiatric implications of the Parkland School massing shooting, here are highlights from the week in Psychiatric Times.

Does the YOI intervention improve mental health workers’ insomnia? Research says yes.

Good night, sleep tight! Researchers performed a 9-year follow-up of sleep disturbance and ADHD symptoms in a population-based cohort study.

An expert panel concludes the discussion by reviewing factors to consider when diagnosing and treating narcolepsy.

A group of specialists discuss treatment options for patients experiencing daytime sleepiness and anxiety.

Thought leaders discuss what elements to consider when distinguishing between cataplexy and pseudo cataplexy.

Thomas E. Scammell, MD reviews the history and current symptoms of a patient with narcolepsy.

Thought leaders consider the role of newer medications in the therapeutic landscape.

Thomas E. Scammell, MD; Heidi Moawad, MD; Phyllis C. Zee, MD, PhD; and Ruth Benca, MD, PhD, discuss abuse, side effects, and other obstacles associated with traditional medications.

Thomas E. Scammell, MD; Heidi Moawad, MD; Phyllis C. Zee, MD, PhD; and Ruth Benca, MD, PhD, discuss the advantages and disadvantages of specific drug mechanisms for the treatment of narcolepsy.

A multidisciplinary panel of sleep experts reviews the role of light exposure, exercise, and other non-pharmacological methods in narcolepsy management.

Thought leaders discuss clinical considerations regarding the many intersecting and complicating conditions that individuals with narcolepsy may experience.

Heidi Moawad, MD; Phyllis C. Zee, MD, PhD; and Ruth Benca, MD, PhD, share details about a patient case that may impact clinical considerations and therapeutic decision-making.